Piperaquine

GPTKB entity

Statements (58)
Predicate Object
gptkbp:instance_of gptkb:drug
gptkbp:bfsLayer 7
gptkbp:bfsParent gptkb:piperaquine
gptkbp:activities inhibits heme polymerization
gptkbp:appointed_by oral tablet
gptkbp:approves gptkb:2000
gptkb:China
gptkbp:availability prescription only
gptkbp:brand gptkb:Piperaquine_phosphate
gptkbp:can_be_used_with gptkb:artesunate
gptkbp:clinical_trial Phase III
studied for safety in children
studied for efficacy in adults
studied for use in pregnancy
studied in combination with other antimalarials
used in endemic regions
used in non-endemic regions
gptkbp:composed_of requires multiple synthetic steps
synthesized from 4-aminoquinoline derivatives
gptkbp:contraindication severe renal impairment
severe liver impairment
hypersensitivity to piperaquine
gptkbp:developed_by Chinese researchers
gptkbp:distribution widely used in Southeast Asia
gptkbp:excretion urine
gptkbp:formulation tablet form
suspension form
https://www.w3.org/2000/01/rdf-schema#label Piperaquine
gptkbp:ingredients C24 H30 Cl2 N4 O2
gptkbp:interacts_with anticoagulants
antiretrovirals
anticonvulsants
gptkbp:invention patented
generic versions available
gptkbp:is_used_for treatment of malaria
gptkbp:lifespan approximately 10 days
gptkbp:marketed_as various brand names
gptkbp:metabolism primarily hepatic
gptkbp:provides_information_on used in combination therapy
CDC recommendations for malaria treatment
WHO guidelines for malaria treatment
gptkbp:research ongoing studies on efficacy
studies on pediatric use
studies on pharmacokinetics
studies on drug interactions
studies on safety in pregnancy
gptkbp:research_focus combination therapies
malaria resistance
gptkbp:safety_features generally well tolerated
gptkbp:side_effect dizziness
headache
nausea
abdominal pain
vomiting
gptkbp:storage store in a cool, dry place
gptkbp:targets gptkb:Plasmodium_falciparum
gptkb:Plasmodium_vivax
gptkbp:type_of 100982-00-3